Selective inhibitors of vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity

By Farina C.   Gagliardi S.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 157-168

Informa Healthcare

Access to resources Recommend Favorite

In Silico Ligand-Receptor Docking of Potentially Selective Butyrylcholinesterase Inhibitors Structurally Related to the Marine Natural Product Debromoflustramine B

By  

Medicinal Chemistry, Vol. 6, Iss. 3, 2010-05 ,pp. : 141-143

Bentham Science Publishers

Access to resources Recommend Favorite

Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H⁺-ATPase as an emerging target

By Kartner Norbert   Manolson Morris F  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 505-522

Informa Healthcare

Access to resources Recommend Favorite

Natural Product Origins of Hsp90 Inhibitors

By  

Current Cancer Drug Targets, Vol. 3, Iss. 5, 2003-10 ,pp. : 325-330

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Product Inhibitors of the Ubiquitin-Proteasome Pathway

By  

Current Drug Targets, Vol. 12, Iss. 11, 2011-10 ,pp. : 1581-1594

Bentham Science Publishers

Access to resources Recommend Favorite